Design, Synthesis, and Biological Evaluation of Potent and Selective Class IIa Histone Deacetylase (HDAC) Inhibitors as a Potential Therapy for Huntington’s Disease
Roland W. Bürli(Covance (United Kingdom)), Celia Dominguez(CHDI Foundation), Perla Breccia, George McAllister, Philip M. Leonard, Marieke Lamers, Vahri Beaumont(University of Bristol), Rebecca E. Jarvis, Julie Vann, Michel Maillard(CHDI Foundation), Alan F. Haughan, Ignacio Muñoz-Sanjuán(CHDI Foundation), Liz Stones, Christine M. Richardson, Hannah McNeil, Grant Wishart(Charles River Laboratories (United Kingdom)), Maria Beconi(CHDI Foundation), Kathy Lyons, John E. Mangette(Albany Molecular Research (United States)), Samantha Jane Hughes(University of Trás-os-Montes and Alto Douro), Andrew J. Stott, Kim L. Matthews, Ilka Müller, Christopher A. Luckhurst, Dawn Yates, Omar Aziz, Stephen D. Penrose, Catherine M. O’Connell(California Institute of Technology), Michael E. Wall(Los Alamos National Laboratory), Tania Mead
Cited by 149
Related Papers
Singular Value Decomposition and Principal Component Analysis
|Kluwer Academic Publishers eBooks|2005|1.2k
Design of gene circuits: lessons from bacteria
|Nature Reviews Genetics|2004|236
Allostery in a Coarse-Grained Model of Protein Dynamics
|Physical Review Letters|2005|165
Scaling molecular dynamics beyond 100,000 processor cores for large‐scale biophysical simulations
|Journal of Computational Chemistry|2019|125